Saphyre Wins Innovation in Pre and Post-Trade Ops Solutions by The TRADE
Saphyre, Inc., a leading pre- and post-trade platform for the world's largest financial institutions, was awarded Innovation in Pre and Post-Trade Ops Solutions by The TRADE at the magazine's Leaders ...
Pfizer Names Chris Boshoff Chief Scientific Officer And President, R&D, Effective Jan.1
Drug major Pfizer Inc. (PFE) announced Wednesday the appointment of Chris Boshoff as Chief Scientific Officer and President, Research ...
C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors
Hoerter Brings Over Three Decades of Oncology Commercialization and Leadership ExperienceAppointment Underscores Continued ...
EUCLEAK: More products vulnerable to cloning attack
The EUCLEAK side-channel vulnerability was also known as the "Yubikey cloning attack". The BSI re-certified updated products ...
Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum As 120+ Key Companies At The Forefront Delveinsight
In September 2024, UCB and Biogen reported successful results from their Phase III clinical trial of the PHOENYCS GO study, which tested dapirolizumab pegol as a treatment for moderate-to-severe ...
Under-the-skin Keytruda comparable to infused version in Phase 3 study, Merck says
Merck plans to discuss the data with regulators as it lags rivals Roche and Bristol Myers in bringing forward a subcutaneous ...